• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

    8.360 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 25, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,661
    Open 8.360
    Bid (Size) 8.430 (100)
    Ask (Size) 8.600 (100)
    Prev. Close 8.360
    Today's Range 8.360 - 8.360
    52wk Range 2.960 - 40.37
    Shares Outstanding 45,711,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    CAPR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Capricor Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Urges Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
    Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
    Via NewMediaWire
    Topics Lawsuit

    Performance

    YTD
    -70.5%
    -70.5%
    1 Month
    -12.8%
    -12.8%
    3 Month
    -64.9%
    -64.9%
    6 Month
    -69.9%
    -69.9%
    1 Year
    +12.8%
    +12.8%

    More News

    Read More
    News headline image
    CAPRICOR DEADLINE SEPTEMBER 28th: Bragar Eagel & Squire, P.C. Urges Capricor Therapeutics, Inc. Investors With Large Losses to Contact the Firm Before the September 28th Deadline
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Kaplan Fox Urges Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Seek a Leadership Role Before September 28, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Announces a Securities Class Action Filed Against Capricor Therapeutics, Inc. (NASDAQ: CAPR) - Lead Plaintiff Deadline is September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Capricor Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Capricor Therapeutics, Inc. - CAPR
    From SkyMedia, LLC
    Via GlobeNewswire
    News headline image
    Kaplan Fox Continues to Remind Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors of the Lead Plaintiff Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Capricor Therapeutics, Inc. (CAPR)
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Continues to Alert Investors of a Securities Class Action Deadline on September 28, 2026 Against Capricor Therapeutics, Inc. (NASDAQ: CAPR)
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    CAPR 5-DAY DEADLINE: Capricor Investors Have Opportunity to Lead Class Action - HBSS
    From Hagens Berman
    Via Business Wire
    News headline image
    Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Capricor Therapeutics, Inc. Notice of September 28, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
    From Kahn Swick & Foti, LLC
    Via GlobeNewswire
    News headline image
    CAPRICOR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important September 28 Deadline in Securities Class Action - CAPR
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Capricor Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – CAPR
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Continues to Alert Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to a Class Action Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    CAPRICOR THERAPEUTICS, INC. (CAPR) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Capricor Therapeutics, Inc. Investors of Upcoming Deadline
    From Bernstein Liebhard LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors Seeking Recovery to Contact the Firm Before September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Bragar Eagel & Squire, P.C. Urges Capricor Therapeutics, Inc. Investors With Large Losses to Contact the Firm Before the September 28th Deadline
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    CAPR Investors Have Opportunity to Lead Capricor Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
    From Schall, Brown & Schwartz LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Alerts Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to a Securities Fraud Lawsuit – Lead Plaintiff Deadline is September 28, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Capricor Therapeutics, Inc. (NASDAQ: CAPR) Investors to Contact the Firm Before the Lead Plaintiff Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit
    News headline image
    Kaplan Fox Advises Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) of an Upcoming Securities Class Action Deadline on September 28, 2026
    From Kaplan Fox & Kilsheimer, LLP
    Via GlobeNewswire
    News headline image
    Kaplan Fox Encourages Investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) to Contact the Firm Before Lead Plaintiff Deadline on September 28, 2026
    Via NewMediaWire
    Topics Lawsuit

    Frequently Asked Questions

    Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
    Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
    The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
    What is the current price of Capricor Therapeutics, Inc. - Common Stock?
    The current price of Capricor Therapeutics, Inc. - Common Stock is 8.360
    When was Capricor Therapeutics, Inc. - Common Stock last traded?
    The last trade of Capricor Therapeutics, Inc. - Common Stock was at 09/25/26 04:00 PM ET
    What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
    The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 382.15M
    How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
    Capricor Therapeutics, Inc. - Common Stock has 382M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.